Detalhe da pesquisa
1.
Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesis.
Br J Cancer
; 129(8): 1225-1237, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37620408
2.
Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated Death.
Neuroendocrinology
; 111(10): 965-985, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33108790
3.
Serum levels of advanced glycation end products and their receptors sRAGE and Galectin-3 in chronic pancreatitis.
Pancreatology
; 20(2): 187-192, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31870801
4.
Analysis of GPRC6A variants in different pancreatitis etiologies.
Pancreatology
; 20(7): 1262-1267, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32859544
5.
Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.
Gut
; 67(10): 1855-1863, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28754779
6.
Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.
Int J Cancer
; 143(7): 1806-1816, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29696624
7.
Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity.
Gastroenterology
; 152(6): 1507-1520.e15, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28188746
8.
Common variants in the CLDN2-MORC4 and PRSS1-PRSS2 loci confer susceptibility to acute pancreatitis.
Pancreatology
; 18(5): 477-481, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29884332
9.
Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer.
Gut
; 66(7): 1278-1285, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27013602
10.
p53 family members in myogenic differentiation and rhabdomyosarcoma development.
Cancer Cell
; 10(4): 281-93, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17045206
11.
Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions.
Gut
; 62(7): 1034-43, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22677720
12.
Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer.
iScience
; 26(6): 106841, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37255660
13.
p73 poses a barrier to malignant transformation by limiting anchorage-independent growth.
EMBO J
; 27(5): 792-803, 2008 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-18239687
14.
IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2.
Cancers (Basel)
; 14(9)2022 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565249
15.
CUX1 Enhances Pancreatic Cancer Formation by Synergizing with KRAS and Inducing MEK/ERK-Dependent Proliferation.
Cancers (Basel)
; 13(10)2021 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34070180
16.
p53 and p73 in suppression of Myc-driven lymphomagenesis.
Int J Cancer
; 124(2): 502-6, 2009 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18942718
17.
Common variants in glyoxalase I do not increase chronic pancreatitis risk.
PLoS One
; 14(10): e0222927, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31661534
18.
miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer.
Oncoimmunology
; 5(6): e1160181, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27471627
19.
CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms.
Endocr Relat Cancer
; 21(6): 879-90, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25248790
20.
WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer.
Neoplasia
; 15(1): 11-22, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23359789